These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [QTc-interval prolongation in therapy with atypical antipsychotics--results of an open, non-randomized survey]. Finzel M; Fric M; Laux G Psychiatr Prax; 2004 Nov; 31 Suppl 1():S178-80. PubMed ID: 15570546 [TBL] [Abstract][Full Text] [Related]
3. [Thioridazine and the warning about prolonged QT time]. Laisalmi M Duodecim; 2002; 118(24):2518. PubMed ID: 12572286 [No Abstract] [Full Text] [Related]
4. [Antipsychotic agents and the heart]. Huttunen MO Duodecim; 2002; 118(15):1579. PubMed ID: 12244632 [No Abstract] [Full Text] [Related]
5. QTc prolongation: chlorpromazine and high-dosage olanzapine. Gurovich I; Vempaty A; Lippmann S Can J Psychiatry; 2003 Jun; 48(5):348. PubMed ID: 12866343 [No Abstract] [Full Text] [Related]
6. Antipsychotic induced prolongation of QTc interval treated with magnesium. Imran N; Rampes H; Rosen S J Psychopharmacol; 2003 Sep; 17(3):346-9. PubMed ID: 14513929 [TBL] [Abstract][Full Text] [Related]
8. [Psychotropic drugs and the risk of arrhythmias]. Toivonen L Duodecim; 2002; 118(12):1223-4. PubMed ID: 12239813 [No Abstract] [Full Text] [Related]
9. The prolongation of QTc-interval by thioridazine. Sachdev P Aust N Z J Psychiatry; 2001 Dec; 35(6):857-8. PubMed ID: 11990903 [No Abstract] [Full Text] [Related]
10. [Reduction of prolonged QTc-interval related risks in treatment with neuropharmacological drugs. Recommendations for clinical practice]. van de Kraats GB; Slob J; Tenback DE Tijdschr Psychiatr; 2007; 49(1):43-7. PubMed ID: 17225205 [TBL] [Abstract][Full Text] [Related]
11. Effective electroconvulsive therapy in a 92-year-old dementia patient with psychotic feature. Katagai H; Yasui-Furukori N; Kikuchi A; Kaneko S Psychiatry Clin Neurosci; 2007 Oct; 61(5):568-70. PubMed ID: 17875038 [TBL] [Abstract][Full Text] [Related]
12. Neuroleptic use in a patient with a prolonged QTc interval. Winter EC; Alessi LE Psychosomatics; 2008; 49(3):272-3. PubMed ID: 18448786 [No Abstract] [Full Text] [Related]
13. QTc prolongation: possible association with risperidone and/or haloperidol. Nandagopal JJ; Craig JM; Lippmann S Psychosomatics; 2003; 44(6):521. PubMed ID: 14597690 [No Abstract] [Full Text] [Related]
15. Two cases of amisulpride overdose: a cause for prolonged QT syndrome. Ward DI Emerg Med Australas; 2005 Jun; 17(3):274-6. PubMed ID: 15953230 [TBL] [Abstract][Full Text] [Related]
16. Possible Lurasidone-Associated Dose-Dependent QTc Prolongation in First-Episode Psychosis. Naguy A; Al-Khadhari S; Pridmore S Psychopharmacol Bull; 2022 Jun; 52(3):68-71. PubMed ID: 35815172 [TBL] [Abstract][Full Text] [Related]
17. [Risk of QTc prolongation due to combination of ziprasidone and quetiapine]. Minov C Psychiatr Prax; 2004 Nov; 31 Suppl 1():S142-4. PubMed ID: 15570533 [TBL] [Abstract][Full Text] [Related]
18. Increase in the risk of chlorpromazine-induced QT prolongation during nighttime: is a short-period ECG during daytime sufficient? Suzuki Y; Watanabe J; Ono S; Fukui N; Sugai T; Tsuneyama N; Someya T Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):1122-3. PubMed ID: 20394793 [No Abstract] [Full Text] [Related]
19. Olanzapine-induced QTc prolongation in a patient with Wolff-Parkinson-White syndrome. Su KP; Lane HY; Chuang CL; Chen KP; Shen WW Schizophr Res; 2004 Feb; 66(2-3):191-2. PubMed ID: 15061254 [No Abstract] [Full Text] [Related]
20. QTc interval lengthening and debrisoquine metabolic ratio in psychiatric patients treated with oral haloperidol monotherapy. LLerena A; Berecz R; de la Rubia A; Dorado P Eur J Clin Pharmacol; 2002 Jun; 58(3):223-24. PubMed ID: 12162273 [No Abstract] [Full Text] [Related] [Next] [New Search]